Acute myeloid leukemia trials in Hungary
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- Budapest, Debrecen, Győr, Pécs, Szeged
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06852222EU 2024-520154-38-00Registry updated 2026-11-03
Phase 3RecruitingTrial-stage medicine
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Budapest VIII, Debrecen, Győr, Szekszárd
- Age
- 12 years and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958EU 2025-522279-27-00Registry updated 2026-10-21
Phase 3RecruitingTrial-stage medicine
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Where
- Budapest IX, Debrecen, Győr, Kaposvár, Nyíregyháza
- Age
- 18 years and over
- People
- 1,300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT07007312EU 2025-521314-25-00Registry updated 2026-10-13
Phase 2/3RecruitingTrial-stage medicine
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Where
- Budapest VIII, Debrecen, Győr, Szeged
- Age
- 18 years and over
- People
- 316 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04256317EU 2024-515098-93-00Registry updated 2026-10-06
Phase 2Enrolling by invitationTrial-stage medicine
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Where
- Debrecen
- Age
- 18 years and over
- People
- 332 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04093570EU 2024-516293-29-01Registry updated 2026-07-28
Phase 1RecruitingResearch participation
A Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Budapest
- Age
- Up to 17 years
- People
- 18 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-520125-36-00EU 2024-520125-36-00Registry updated 2026-07-22
Phase 3RecruitingTrial-stage medicine
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
- Where
- Budapest VIII, Debrecen, Pécs, Szeged
- Age
- 18 years and over
- People
- 245 worldwide
- Run by
- Servier Affaires Médicales
See details and how to joinNCT05907057EU 2022-501709-11-00Registry updated 2026-05-08
All Acute myeloid leukemia trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.